Your browser doesn't support javascript.
loading
Cost-utility analysis of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer in the Philippines.
Genuino, Anne Julienne; Chaikledkaew, Usa; Guerrero, Anna Melissa; Reungwetwattana, Thanyanan; Thakkinstian, Ammarin.
Affiliation
  • Genuino AJ; Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Bangkok, Thailand.
  • Chaikledkaew U; Pharmaceutical Division, Department of Health Philippines, Manila, Philippines.
  • Guerrero AM; Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Bangkok, Thailand. usa.chi@mahidol.ac.th.
  • Reungwetwattana T; Social and Administrative Pharmacy Excellence Research (SAPER) Unit, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, 447 Sri-Ayudhaya Rd., Phayathai, Ratchathewi, Bangkok, 10400, Thailand. usa.chi@mahidol.ac.th.
  • Thakkinstian A; Pharmaceutical Division, Department of Health Philippines, Manila, Philippines.
BMC Health Serv Res ; 19(1): 874, 2019 Nov 21.
Article in En | MEDLINE | ID: mdl-31752849

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Chemotherapy, Adjuvant / Trastuzumab / Antineoplastic Agents, Immunological Type of study: Health_economic_evaluation / Prognostic_studies Limits: Female / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: BMC Health Serv Res Journal subject: PESQUISA EM SERVICOS DE SAUDE Year: 2019 Type: Article Affiliation country: Thailand

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Chemotherapy, Adjuvant / Trastuzumab / Antineoplastic Agents, Immunological Type of study: Health_economic_evaluation / Prognostic_studies Limits: Female / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: BMC Health Serv Res Journal subject: PESQUISA EM SERVICOS DE SAUDE Year: 2019 Type: Article Affiliation country: Thailand